Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson's disease
Petar Podlesniy1, Dolores Vilas2, Peggy Taylor3
1Neurobiology Unit, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (CSIC), Spain; Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Abstract:
Mitochondrial DNA regulates mitochondrial function which is altered in both idiopathic and familial forms of Parkinson's disease. To investigate whether these two disease forms exhibit an altered regulation of mitochondrial DNA we measured cell free mitochondrial DNA content in cerebrospinal fluid (CSF) from idiopathic and LRRK2-related Parkinson's disease patients. The concentration of mitochondrial DNA was measured using a digital droplet polymerase chain reaction technique in a total of 98 CSF samples from a cohort of subjects including: 20 LRRK2(G2019S) mutation carriers with Parkinson's disease, 26 asymptomatic LRRK2(G2019S) mutation carriers, 31 patients with idiopathic Parkinson's disease and 21 first-degree relatives of LRRK2 Parkinson's disease patients without the mutation. Here we report that LRRK2(G2019S) mutation carriers with Parkinson's disease exhibit a high concentration of mitochondrial DNA in CSF compared with asymptomatic LRRK2(G2019S) mutation carriers and with idiopathic Parkinson's disease patients. In addition, idiopathic, but not LRRK2 Parkinson's disease is associated with low CSF concentration of α-synuclein. These results show that high mitochondrial DNA content in CSF distinguishes idiopathic from LRRK2-related Parkinson's disease suggesting that different biochemical pathways underlie neurodegeneration in these two disorders.
Insights
High mitochondrial DNA in cerebrospinal fluid (CSF) distinguishes LRRK2-related Parkinson's disease from idiopathic forms. This finding suggests different neurodegenerative pathways in these Parkinson's disease subtypes.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Mitochondrial DNA (mtDNA) plays a crucial role in mitochondrial function.
- Altered mtDNA regulation is observed in both idiopathic and familial Parkinson's disease (PD).
- Investigating mtDNA differences can elucidate distinct pathogenic mechanisms in PD subtypes.
Purpose of the Study:
- To compare cell-free mitochondrial DNA (cf-mtDNA) content in cerebrospinal fluid (CSF) between idiopathic PD and LRRK2-related PD.
- To determine if cf-mtDNA levels can differentiate between these two forms of Parkinson's disease.
- To explore the association of CSF α-synuclein levels with idiopathic and LRRK2-related PD.
Main Methods:
- Measured cf-mtDNA concentration in 98 CSF samples using digital droplet polymerase chain reaction (ddPCR).
- Analyzed samples from LRRK2(G2019S) mutation carriers with PD, asymptomatic LRRK2(G2019S) carriers, idiopathic PD patients, and non-carrier relatives.
- Quantified CSF α-synuclein concentrations.
Main Results:
- LRRK2(G2019S) mutation carriers with PD showed significantly higher CSF cf-mtDNA concentrations compared to asymptomatic carriers and idiopathic PD patients.
- Idiopathic PD patients exhibited lower CSF α-synuclein levels compared to LRRK2-related PD.
- Asymptomatic LRRK2(G2019S) carriers had higher cf-mtDNA levels than non-carrier relatives.
Conclusions:
- Elevated CSF cf-mtDNA levels are a potential biomarker distinguishing LRRK2-related PD from idiopathic PD.
- These findings suggest distinct underlying biochemical pathways in the neurodegeneration of idiopathic and LRRK2-related Parkinson's disease.
- CSF cf-mtDNA and α-synuclein levels may serve as differential diagnostic markers for Parkinson's disease subtypes.
More Related Videos
08:55Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Related Concept Videos
Neural Regulation
Lysosomal Hydrolases
Animal Mitochondrial Genetics
